Treatment of psychological trauma

1. A method of treating or reducing the occurrence of at least one symptom of a psychological trauma disorder in a patient in need thereof, the method comprising the step of administering to the mammal in need thereof a therapeutically effective amount of a composition including a botulinum neurotoxin (BoNT) and/or a Targeted Exocytosis Modulator (TEM), wherein administration of the composition reduces the at least one symptom of the psychological trauma disorder, thereby treating the patient, wherein the at least one symptom of the psychological trauma disorder comprises total or partial amnesia of a traumatic event, flashbacks or nightmares wherein the patient re-experiences the traumatic event, avoidance of stimuli associated with the traumatic event, increased arousal including difficulty falling or staying asleep, anger, hyper-vigilance or combinations thereof.

2. The method of claim 1 , wherein the BoNT and/or TEM are administered to an Arnold's nerve or a nerve from the recurrent laryngeal nerve complex.

3. The method of claim 1 , wherein the BoNT and/or TEM are administered to: the frontalis at divided among four sites of administration; to the corrugator divided among two sites of administration; to the procerus at one site of administration; to the occipitalis at six sites to eight sites of administration; to the temporalis at eight sites to ten sites of administration; to the trapezius at six sites to ten sites of administration and to the cervical paraspinal muscles at four sites of administration.

4. The method of claim 1 , wherein the BoNT and/or TEM are administered to the glabellar complex.

5. The method of claim 1 , wherein the BoNT is BoNT/A.

6. The method of claim 1 , wherein the psychological trauma disorder is a post-traumatic stress disorder.

7. The method of claim 1 , wherein the psychological trauma disorder is a complex post-traumatic stress disorder.